| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bicycle Therapeutics Plc (BCYC) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. BCYC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 10.02M | $40.07M | - | |
| CEO | 611.3K | $2.45M | - | |
| Dir | 196.4K | $785.7K | - | |
| Other | 159.6K | $638.2K | - | |
| COO | 136.7K | $546.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2021 | Lee Kevin75 | Chief Executive Officer | Sale+OE | 7,320 | $32.21 | $235,769.16 | -1.4% | -5.9% | -35.6% | |
| May 4, 2021 | Lee Kevin75 | Chief Executive Officer | Sale+OE | 4,288 | $32.13 | $137,785.47 | -0.8% | -1.5% | -27.0% | |
| Apr 30, 2021 | Lee Kevin75 | Chief Executive Officer | Sale+OE | 58,919 | $30.86 | $1,817,987.66 | -2.7% | +0.6% | -24.3% | |
| Apr 27, 2021 | Lee Kevin75 | Chief Executive Officer | Sale+OE | 25,247 | $31.13 | $785,872.71 | -2.4% | +13.1% | -19.3% | |
| Apr 8, 2021 | Legault Pierre61 | Director | Sale+OE | 24,838 | $31.71 | $787,587.67 | -66.4% | -2.7% | +45.6% | |
| Apr 5, 2021 | Legault Pierre61 | Director | Sale+OE | 162 | $31.07 | $5,033.34 | -100% | +4.8% | +44.0% | |
| Mar 31, 2021 | Keen Nicholas64 | Chief Scientific Officer | Sell | 10,000 | $30.00 | $300,000.00 | -26.1% | +0.7% | +46.9% | |
| Mar 31, 2021 | Legault Pierre61 | Director | Sale+OE | 10,000 | $30.00 | $300,000.00 | -100% | +0.7% | +46.9% | |
| Mar 17, 2021 | Legault Pierre61 | Director | Sale+OE | 7,784 | $29.00 | $225,736.00 | -100% | +6.5% | +48.1% | |
| Mar 15, 2021 | Keen Nicholas64 | Chief Scientific Officer | Sell | 10,000 | $28.48 | $284,843.00 | -8.0% | +4.6% | +47.8% |